DevOps & Cloud

Deployment, cloud, containers, CI/CD, monitoring, and infrastructure

skills in category: 20,289
pages available: 846

Security grades appear on each card once the skill has been scanned. Newly imported skills may briefly show without a grade until the backfill job runs.

Open in full browser

Browse devops & cloud skills

Showing 9,817–9,840 of 20,289 skills

Ata Ppgl Biomarker Use For PrognosisAThis skill guides the use of biomarkers to prognosticate metastatic pheochromocytoma and paraganglioma (PPGL) by applying independent prognostic factors such as older age, larger tumor size, metastases at diagnosis, multiple metastases, high chromogranin A, plasma fractionated metanephrines ≥5× ULN, or elevated plasma 3‑MT; for head‑and‑neck PPGL, only high blood 3‑MT predicts disease‑specific survival. It is triggered when a clinician asks about prognosis based on biomarker results or encoun...devopsrailstestingVotes: 0GitHub stars: 12
Eso Pediatric Obesity Infant DiagnosisADiagnoses obesity in infants and toddlers under 2 years of age when sex-specific weight-for-recumbent length is at or above the 97.7th percentile on WHO growth charts. Consider this assessment during well-child visits when caregivers report excessive weight gain, crossing of percentile channels, or when length and weight measurements suggest disproportionate adiposity.devopsgorailsVotes: 0GitHub stars: 12
Endo Prefer Nsaid DmardARecommends using NSAIDs or DMARDs instead of glucocorticoids for chronic inflammatory disease (e.g., rheumatoid arthritis) to limit weight gain. Triggered when clinicians ask, “What anti‑inflammatory should I choose for this RA patient to avoid weight gain?” or “Should I avoid steroids in this obese patient with RA?”devopsgorailsVotes: 0GitHub stars: 12
Endo Comorbidities Longitudinal MonitoringAThis skill recommends longitudinal monitoring and rigorous management of identified comorbidities—such as hypertension, diabetes mellitus, cardiovascular disease, osteoarthritis, and sleep apnea—in patients with acromegaly. Apply throughout follow‑up when comorbidities are present to mitigate morbidity and mortality risk.devopsgorailsVotes: 0GitHub stars: 12
Endo Paget Repeat Xray Osteolytic LesionsAThis skill outlines when to obtain a repeat radiograph approximately one year after radiological diagnosis of osteolytic lesions in Paget's disease to assess lesion improvement or worsening. Consider repeat imaging if biochemical markers of bone turnover remain elevated or bone pain persists despite therapy.devopsgorailsVotes: 0GitHub stars: 12
Endo Tg Check Bile Acid SequestrantAThis skill recommends checking triglyceride levels before and after starting a bile acid sequestrant in patients with elevated triglycerides (150-499 mg/dL). Clinical triggers include: triglyceride level 150-499 mg/dL, consideration of bile acid sequestrant for hypertriglyceridemia, and monitoring of therapeutic response to bile acid sequestrant.devopsrailsVotes: 0GitHub stars: 12
Skills DirectorySkills Directory Look up any of 103,619 scanned skills — grade, score, and every finding. Free.Check a skill
Endo Measure Lipid Profile Before After Acromegaly TreatmentASuggests measurement of the usual lipid profile before and after treatment of growth hormone excess in adults with acromegaly. Triggers include: patient with acromegaly starting treatment, assessing lipid changes after GH suppression therapy, lipid monitoring in acromegaly management.devopsrailsVotes: 0GitHub stars: 12
Endo Lipid Reassessment Weight Loss ObesityAReassesses lipid profile after 5% weight loss in obese patients on pharmacological weight loss therapy to evaluate cardiovascular disease and pancreatitis risk.devopsrailsVotes: 0GitHub stars: 12
Gcih Patient ClassifierAClassify a hospitalised patient on glucocorticoids as established diabetic (Group 1) or new glucocorticoid-induced hyperglycemia without prior DM (Group 2), then determine whether background basal-bolus insulin is needed and at what starting dose based on HbA1c. Trigger when a clinician asks "does this steroid patient need background insulin", "starting insulin dose for steroid-induced diabetes", "how to manage GCIH in a known diabetic vs new hyperglycemia", "background insulin for prednisolo...devopsrailsVotes: 0GitHub stars: 12
Es Preop Hba1c FactorsAConsider factors that may affect hemoglobin A1c when interpreting preoperative levels for adults with diabetes undergoing elective surgery. Triggered by questions such as "Are there conditions that might make HbA1c unreliable for this patient?" when anemia, hemoglobinopathies, chronic renal failure, alcoholism, drugs, or large blood glucose variations are present.devopsgorailsVotes: 0GitHub stars: 12
Es Icr AdjustmentAAdjusts the insulin-to-carbohydrate ratio (ICR) for hospitalized patients with diabetes when illness or treatments alter insulin requirements. Triggered by clinician statements such as "Patient's insulin needs changed due to infection, should we adjust the carb ratio?" or "Glucose-interfering medications necessitate ICR modification."devopsrailsVotes: 0GitHub stars: 12
Es Ghc Hypoglycemia SafeguardsAThis skill guides clinicians to apply safeguards—including frequent point-of-care glucose monitoring and insulin dose adjustments—to prevent hypoglycemia when tapering or discontinuing glucocorticoids in hospitalized patients. Use when encountering triggers such as "Glucocorticoid being tapered, how to avoid hypoglycemia?" or "Stopping steroids, need to avoid low blood sugar."devopsgorailsVotes: 0GitHub stars: 12
Es Ghc Add Nph To BbiAIn patients already on a basal bolus insulin (BBI) regimen who develop hyperglycemia while receiving glucocorticoids, consider adding neutral protamine Hagedorn (NPH) insulin to the regimen. Trigger phrases include: "Patient is on BBI, should we add NPH for steroid coverage?" or "Glucocorticoid-associated hyperglycemia on BBI, consider NPH addition."devopsgorailsVotes: 0GitHub stars: 12
Es Dces Resource TrainingAWhen diabetes care and education specialist (DCES) availability is limited, availability is limited, the DCES serves as a resource to train healthcare providers (e.g., staff nurses, pharmacists, dietitians) to deliver inpatient diabetes education. Trigger phrases include "DCES scarce, how to still provide diabetes education?"devopsrailsVotes: 0GitHub stars: 12
Es Continue Scheduled Insulin ModifiedARecommend continuation of the pre‑admission scheduled insulin regimen, adjusted for nutritional status and severity of illness, to keep glucose between 100‑180 mg/dL in hospitalized adults with insulin‑treated diabetes. Triggered by clinician questions such as “Patient was on insulin before admission, how should we adjust their regimen in hospital?” or similar.devopsrailsVotes: 0GitHub stars: 12
Es Basal Insulin Dose ReductionAConsider reducing basal insulin dose by 10% to 20% at hospitalization for patients on basal heavy insulin regimens (≥0.6–1.0 units/kg/day) to prevent over‑coverage of meal‑related glucose excursions. Trigger phrases include “Patient on high basal insulin dose, should we reduce it during hospital stay?” and “Basal insulin dose ≥0.6 U/kg/day, consider reduction on admission.”devopsrailsVotes: 0GitHub stars: 12
Endo Inpatient Ehr Glycemic Surveillance Vs Standard CareARecommends implementing inpatient glycemic surveillance and management programs that leverage EHR data to identify and mitigate hypoglycemia risk versus standard care. Triggered by establishing hypoglycemia reduction programs, using EHR alerts for glucose trends, or responding to CMS hypoglycemia quality measures.devopsrailsVotes: 0GitHub stars: 12
Endo Continue Scheduled Insulin Modify Nutritional Severity Basal Dose ReductionAThe clinician continues the patient's pre‑admission scheduled insulin regimen, adjusting it for current nutritional status and illness severity to keep glucose between 100–180 mg/dL. Trigger phrases include a basal insulin dose ≥0.6 units/kg/day, altered nutritional intake, or worsening illness severity.devopsrailsVotes: 0GitHub stars: 12
Icsm Testosterone Monitoring ScheduleAThis skill outlines the monitoring schedule for testosterone therapy, detailing baseline, 3‑month, 6‑month, and yearly assessments of symptoms, adverse events, total testosterone, hematocrit, PSA, and DRE. Use it when a patient is receiving testosterone and the clinician asks what labs and checks are needed today or when the next monitoring visit should occur.devopsgorailsVotes: 0GitHub stars: 12
Icsm Prostate Monitoring TtARecommends prostate-specific antigen (PSA) testing and digital rectal examination (DRE) to monitor prostate health during testosterone therapy, following evidence-based guidelines for prostate cancer surveillance. Use when managing a patient on testosterone and questioning whether prostate checks are needed or when PSA/DRE are due.devopsgorailsVotes: 0GitHub stars: 12
Icsm Offer Tt After Rp Favorable Pathology Undetectable PsaAThis skill guides clinicians to consider testosterone therapy in postoperative radical prostatectomy patients who have undetectable PSA and favorable pathology (negative margins, seminal vesicles, and lymph nodes). Trigger when a postoperative patient reports recovered undetectable PSA and pathology is clear, raising the question of initiating testosterone replacement.devopsgonodeVotes: 0GitHub stars: 12
Icsm Offer Tt After Radiation Low Psa ConsentAThis skill guides offering testosterone therapy after radiation or brachytherapy when a patient's PSA has fallen to a low level, typically at 3-6 months post-treatment. It is triggered when clinicians consider initiating testosterone and seek confirmation that the PSA is sufficiently low, accompanied by a consent form discussing uncertainties.devopsgorailsVotes: 0GitHub stars: 12
Icsm Hematocrit Monitoring TtAThis skill guides clinicians to maintain hematocrit below 54% before and during testosterone therapy, with particular attention to high-altitude populations to mitigate polycythemia risk. It is triggered when reviewing labs and asking, "Is the hematocrit safe or do I need to adjust or hold testosterone due to high Hct?"devopsrailsVotes: 0GitHub stars: 12
Icsm Consider Tt Normal Psa No PcaALarge RCTs show no increased prostate cancer risk with testosterone therapy in men without known prostate cancer and normal PSA, supporting its consideration in this population. This skill is triggered when a clinician evaluates a hypogonadal man with normal PSA and no prior cancer diagnosis and questions whether testosterone therapy is safe to initiate.devopsgorailsVotes: 0GitHub stars: 12